Company
Scribe Therapeutics Inc.
Rewriting the story of disease
Also known as Scribe Therapeutics
- Status
- IPOas of 2026-09-20Source (opens in a new tab)
- Business model
- B2B
- Customers
- world-leading pharmaceutical companies
- Legal name
- Scribe Therapeutics
- scribetx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 20 September 2026
About
We’re committed to unlocking the future of medicine by engineering CRISPR-based therapeutics that are safe and effective enough to transform everyone's lifetime risk for disease.
Funding snapshot
- Latest round
- IPO2026-07-27
Funding rounds
- IPO
- 2026-07-27
About the company
- Status notes
- Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
Loading relationship preview